Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4

nork Griffiths, Katherine, Binder, Uli, McDowell, William, Tommasi, Rita, Frigerio, Mark, Darby, William G., Hosking, Chris G., Renaud, Lionel, Machacek, Matthias, Lloyd, Peter, Skerra, Arne, Foley, Michael
Argitaratua izan da MAbs (2019)

Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion

nork Golding, Sarah E., Rosenberg, Elizabeth, Valerie, Nicholas, Hussaini, Isa, Frigerio, Mark, Cockcroft, Xiaoling F., Chong, Wei Yee, Hummersone, Marc, Rigoreau, Laurent, Menear, Keith A., O’Connor, Mark, Povirk, Lawrence F., van Meter, Timothy, Valerie, Kristoffer
Argitaratua 2009

On and off-target effects of telomere uncapping G-quadruplex selective ligands based on pentacyclic acridinium salts

nork Iachettini, Sara, Stevens, Malcolm FG, Frigerio, Mark, Hummersone, Marc G, Hutchinson, Ian, Garner, Thomas P, Searle, Mark S, Wilson, David W, Munde, Manoj, Nanjunda, Rupesh, D’Angelo, Carmen, Zizza, Pasquale, Rizzo, Angela, Cingolani, Chiara, De Cicco, Federica, Porru, Manuela, D’Incalci, Maurizio, Leonetti, Carlo, Biroccio, Annamaria, Salvati, Erica
Argitaratua 2013